Role of cytokines and chemokines in the non-progression of the HIV-1 infection in vertically infected children;Papel de las citocinas y las quimiocinas en la no progresión de la infección por VIH-1 en niños infectados verticalmente

Medicina Clinica

Volumn 114, Issue 17, 2000, Pages 641-646

  Resino, Salvador ^a   Bellón, José María ^a   Jiménez, José Luis ^a   Gurbindo, M Dolores ^a   Muñoz Fernández, M Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Chemokines; Children; Cytokines; HIV; Non progression

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN DERIVATIVE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD; CELL CULTURE; CELL DIVISION; CHILD; DISEASE COURSE; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MONONUCLEAR CELL;

ADOLESCENT; CELL DIVISION; CELLS, CULTURED; CHILD; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HUMANS; INTERLEUKIN-18; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; RANTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041026841     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71389-3     Document Type: Article

References (59)

1. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332: 201-208.
2. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993; 7: 1427-1433.
3. Keet IP, Krol A, Klein MR, Veugelers P, de Wit J, Roos M et al. Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis 1994; 169: 1256-1264.
4. Resino S, Jiménez JL, Gurbindo D, Muñoz-Fernández MA. Marcadores predictivos de supervivencia en niños menores de 12 meses de edad infectados verticalmente por el virus de la inmunodeficiencia humana. Med Clin (Barc) 1999; 113: 561-566.
5. Gurbindo D, Resino S, Sánchez-Ramón S, León JA, Muñoz-Fernández MA. Neurological manifestations of HIV-1 infection in infants: viro-immunologic markers. Neuropediatrics 1999; 30: 197-204.
6. Resino S, Gurbindo MD, Bellón JM, Sánchez-Ramón S, Muñoz-Fernández MA. Predictive markers of clinical outcome in vertically HIV-1 infected infants, a prospective longitudinal study. Pediatr Res 2000; 47: 1-7.
7. Duliege AM, Messiah A, Blanche S, Tardieu M, Griscelli C, Spira A. Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease. Pediatr Infect Dis J 1992; 11: 630-635.
8. Blanche S, Rouzioux C, Moscato ML, Veber F, Mayaux MJ, Jacomet C et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med 1989; 320: 1643-1548.
9. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114 678-693.
10. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993; 5: 165-173.
11. Mosmann TR. Cytokine patterns during the progression to AIDS. Science 1994; 265: 193-194.
12. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575-581.
13. Vigano A, Principi N, Villa ML, Riva C, Crupi L, Trabattoni D et al. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. J Pediatr 1995. 126: 368-374.
14. Clerici M, Shearer GM. A TH1 > TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-111.
15. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93: 768-775.
16. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic. human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91: 759-765.
17. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994; 8: 757-762.
18. Graziosi C, Pantaleo G, Gantl KR, Fortin JP, Demarest JF, Cohen OJ et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV- infected individuals. Science 1994; 265: 248-252.
19. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994; 265: 244-248.
20. Muñoz-Fernández MA, Navarro J, García A, Punzón C, Fernández-Cruz E, Fresno M. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation. J Allergy Clin Immunol 1997; 100: 838-845.
21. Vyakarnam A, McKeating J, Meager A, Beverley PC. Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 1990; 4: 21-27.
22. Obregón E, Börner C, Navarro J, Gurbindo MD, Fernández-Cruz E, Muñoz-Fernández MA. Elevated levels of circulating intercellular adhesion molecule 1 and tumor necrosis factor a in the serum of children vertically infected with HIV-1. Pediatric AIDS and HIV Infection: Fetus and adolescent 1996; 7: 413-417.
23. Graziosi C, Pantaleo G, Fauci AS. Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. Res Immunol 1994; 145: 602-607.
24. Israel-Biet D, Cadranel J, Beldjord K, Andrieu JM, Jeffrey A, Even P. Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991; 147: 490-494.
25. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTFS, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-1815.
26. Kinter AL, Ostrowski M, Goletti D, Oliva A, Weissman D, Gantt K et al. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996; 93: 14076-14081.
27. Vigano A, Balotta C, Trabattoni D, Bricalli D, Crupi L, Palomba E et al. Long-term resistance to HIV infection in vertical HIV nfection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts. Pathobiology 1997; 65: 169-176.
28. Grubman S, Gross E, Lerner-Weiss N, Hernández M, McSherry GD, Hoyt LG et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics 1995; 95: 657-663.
29. Muñoz-Fernández MA, Obregón E, Navarro J, Borner C, Gurbindo MD, Sampelayo TH et al. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr Res 1996; 40: 597-602.
30. Muñoz-Fernández MA, Navarro J, García Montes M, Cosin J, Zabay JM, Fernández-Cruz E. Quantification of low levels of HIV-1 RNA viremia in p24-antigen-negative asymptomatic HIV+ patients by use of the polymerase chain reaction. J Clin Microbiol 1996; 2: 404-408.
31. Pediatric European Network for treatment of AIDS (PENTA). HIV-1 viral load and CD4 cell court in untreated children with vertically acquired asymptomatic or mild disease. AIDS 1998; 12: F1-F8
32. Muñoz-Fernández MA, Resiro S, Navarro J, Obregón E, Jiménez JL, Alonso R. High viral load in children long-term non progressor vertically infected with HIV-1. Immunologyc characterization. En: Editore M, editor. Ginebra: 12th World AIDS Conference Book. 1998; 45-49.
33. Italian Register HIVc. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994; 343: 191-195.
34. a ed.). Filadelfia: 1998; 2169-2226
35. a ed.). 1997; 2169-2226
36. Navarro M, Gurbindo D, Sampelayo T, Muñoz-Fernández MA. SIDA pediátrico. Medicine (Madr) 1998; 7: 3990-3998.
37. Muñoz-Fernández MA, Navarro J, Obregón E, Arias RA, Gurbindo MD, Sampelayo TH. Immunological and virological markers of disease progression in HIV-1 infected children. Acta Paediatr Suppl 1997; 46-51.
38. Blanche S, Newell ML, Mayaux MJ, Dunn DT, Teglas JP, Rouzioux C et al. Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 442-450.
39. Mayaux MJ, Burgard M, Teglas JP, Cottalcrda J, Krivine A, Simon F et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA 1996; 275: 606-610.
40. Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. The European Collaborative Study. Chest 1992; 102: 1899-1901.
41. Scott GB, Hutto C, Makuch RW, Mastrucci MT, O'Connor T, Mitchell CD et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989; 321: 1791-1796.
42. Tovo PA, De Martino M, Gabiano C, Cappello N, D'Flia R, Loy A et al. Prognostic: factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections n Children. Lancet 1992; 339: 1249-1253.
43. Thomas P, Singh T, Williams R, Blum S. Trends in survival for children reported with maternally transmitted acquired immunodeficiency syndrome in New York City, 1982 to 1989. Pediatr Infect Dis J 1992; 11: 34-39.
44. Salmon M, Kitas GD, Bacon PA. Production of lymphokine mRNA by CD45R+ and CD45R-helper T cells from human peripheral blood and by human CD4+ T cell clones. J Immunol 1989; 143: 907-912.
45. Meyaard L, Otto SA, Keet IP, Van Lier RA, Miedema F. Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. Blood 1994; 84: 4262-4268.
46. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993; 262: 1721-1724.
47. Vyakarnam A, Matear PM, Martin SJ, Wagstaff M. Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replicalion in Th0 cells. Immunology 1995; 86: 85-96
48. Clerici M, Fusi ML, Ruzzante S, Piconi S, Biasin M, Arienti D et al. Type 1 and type 2 cytokines in HIV infection - a possible role in apoptosis and disease progression. Ann Med 1997; 29: 185-188.
49. Clerici M, Balotta C, Meroni L, Ferrario E, Riva C, Trabattoni D et al. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses 1996; 12: 1053-1061.
50. Than S, Hu R, Oyaizu N, Romano J, Wang X, Sheikh S et al. Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children. J Infect Dis 1997; 175: 47-56.
51. Moore KW, Vieira P, Florentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-1234.
52. Moore KW, O'Garra A, De Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.
53. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-360.
54. Arditi M, Kabat W, Yogev R. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children. Pediatr Infect Dis J 1991; 10: 450-455.
55. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994; 169: 420-424.
56. McKenzie S, Dallalio G, North M, Frame P, Means R. Serum chemokine levels in patients with non-progressing HIV infection. AIDS 1996; 10: 29-33.
57. Zanussi S, D'Andrea M, Simonelli C, Tirelli U, DePaoli P. Serum levels of RANTES and MIP-1a in HIV-positive long-term survivors and progressor patients. AIDS 1996; 10: 1431-1432.
58. Clerici M, Balotta C, Trabattoni D, Papagno L, Ruzzante S, Rusconi S et al. Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS 1996; 10: 1432-1433.
59. Blazevic V, Heino M, Ranki A, Jussila T, Krohn K. RANTES, MIP, and interleukin-16 in HIV infection. AIDS 1996; 10: 1435-1436.